Intratumoral immunotherapy of murine pheochromocytoma shows no age-dependent differences in its efficacy

Intratumoral immunotherapy of murine pheochromocytoma shows no age-dependent differences in its efficacy

Cancer immunotherapy has shown remarkable clinical progress in recent years. Although age is one of the biggest leading risk factors for cancer development and older adults represent a majority of cancer patients, only a few new cancer immunotherapeutic interventions have been preclinically tested i...

Full description

Bibliographic Details
Main Authors: Ondrej Uher, Katerina Hadrava Vanova, Radka Lencova, Andrea Frejlachova, Herui Wang, Zhengping Zhuang, Jan Zenka, Karel Pacak
Format: Article
Language:English
Published: Frontiers Media S.A. 2023-05-01
Series:Frontiers in Endocrinology
Subjects:
intratumoral immunotherapy
age
pheochromocytoma
TLR ligands
pancreatic adenocarcinoma
anti-CD40 antibody
Online Access:https://www.frontiersin.org/articles/10.3389/fendo.2023.1030412/full

Similar Items

Similar Items